From October 1, 2022 to December 31, 2022, the company has repurchased 827,300 shares, representing 0.1% for CNY 31.5 million. With this, the company has completed the repurchase of 1,257,300 shares, representing 0.15% for CNY 47.3 million under the buyback announced on September 1, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.57 CNY | +1.80% | +4.63% | -43.95% |
May. 24 | Tranche Update on Zhejiang Jiuzhou Pharmaceutical Co., Ltd's Equity Buyback Plan announced on January 5, 2024. | CI |
May. 23 | Jiuzhou Pharmaceutical Plans CRO in Germany | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-43.95% | 1.68B | |
+55.35% | 815B | |
+31.64% | 597B | |
-0.10% | 377B | |
+15.47% | 319B | |
+13.10% | 310B | |
+15.51% | 247B | |
+16.72% | 228B | |
+16.54% | 180B | |
+4.31% | 170B |
- Stock Market
- Equities
- 603456 Stock
- News Zhejiang Jiuzhou Pharmaceutical Co., Ltd
- Tranche Update on Zhejiang Jiuzhou Pharmaceutical Co., Ltd's Equity Buyback Plan announced on September 1, 2022.